Skip to content
Abierto
Menu

Award notice, first published as combined synopsis and solicitation

Blood Donor Screening Tests approved by FDA for Blood Donations - US Naval Hospital Okinawa, Japan

HT941024Q2024

Defense Health Agency (Dha), Defense Health Agency HCD West. In-Vitro Diagnostic Substance Manufacturing.

View on SAM.govMarkdown

Awarded

Bloodworks

$2,482,404.00 on the award notice, February 27, 2024, contract HT941024P0103

Description

As published on SAM.gov.

A firm fixed price contract was awarded to BLOODWORKS for Blood Donor Screening Tests on 27 FEBRUARY 2024. Total Contract value is $2,482,404.00.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Bloodworks
UEI
ZN56PFWUDQK7
CAGE
44701
Vendor location
Seattle, WA
Contract
HT941024P0103, purchase order
Obligated
$160,221.27, current value $543,210, potential $1,613,161
Actions
9 between February 27, 2024 and December 31, 2025
Competition
Competed Under SAP, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
Blood Donor Screening Tests
Match
award number HT941024P0103 equals the contract number; same awarding office HT9410 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. February 20, 2024

    Combined synopsis and solicitation

    Due February 26, 2024 at 10:00 AM EST. SAM.gov, notice f5d37142bf704ff9948b8f8f8088c516

  2. February 21, 2024

    Combined synopsis and solicitation

    Due February 26, 2024 at 10:00 AM EST. SAM.gov, notice fb16c4767b1748b8864f4e9c8920f100

  3. February 27, 2024

    Award notice, originally combined synopsis and solicitation

    Awarded to BLOODWORKS Seattle for $2,482,404. SAM.gov, notice 37b4bd89b3ee465f9e9062df2ace47a1

Points of contact

Also open from this buyer